[1] |
WANG M, WANG Y, FENG X, et al. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center[J]. Int J Infect Dis, 2017, 65: 15-21. DOI: 10.1016/j.ijid.2017.09.003.
|
[2] |
National Health and Family Planning Commission of the People's Republic of China. Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. J Clin Hepatol, 2017, 33(8): 1419-1431. DOI: 10.3969/j.issn.1001-5256.2017.08.003.
中华人民共和国国家卫生和计划生育委员会. 原发性肝癌诊疗规范(2017年版)[J]. 临床肝胆病杂志, 2017, 33(8): 1419-1431. DOI: 10.3969/j.issn.1001-5256.2017.08.003.
|
[3] |
International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia[J]. Hepatology, 2009, 49(2): 658-664. DOI: 10.1002/hep.22709.
|
[4] |
HYTIROGLOU P. Well-differentiated hepatocellular nodule: Making a diagnosis on biopsy and resection specimens of patients with advanced stage chronic liver disease[J]. Semin Diagn Pathol, 2017, 34(2): 138-145. DOI: 10.1053/j.semdp.2016.12.009.
|
[5] |
KOBAYASHI M, IKEDA K, HOSAKA T, et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis[J]. Cancer, 2006, 106(3): 636-647. DOI: 10.1002/cncr.21607.
|
[6] |
DIETRICH CF, KONO Y, COSGROVE D, et al. Contrast enhanced ultrasound: Liver imaging reporting and data system (CEUS LI-RADS)[J]. Ultrasound Med Biol, 2017, 43: s38-s39.
|
[7] |
Abdominal Study Group, Chinese Society of Radiology, Chinese Medical Association. Standard guidelines for abdominal CT scan (trial version)[J]. Chin J Radiol, 2007, 41(9): 999-1004. DOI: 10.3760/j.issn:1005-1201.2007.09.031.
中华医学会放射学分会腹部学组. 腹部CT扫描规范指南(试用稿)[J]. 中华放射学杂志, 2007, 41(9): 999-1004. DOI: 10.3760/j.issn:1005-1201.2007.09.031.
|
[8] |
DING Y, RAO SX, CHEN C, et al. Assessing liver function in patients with HBV-related HCC: A comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI[J]. Eur Radiol, 2015, 25(5): 1392-1398. DOI: 10.1007/s00330-014-3542-x.
|
[9] |
PIETRYGA JA, BURKE LM, MARIN D, et al. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: Examination recovery with a multiple arterial phase acquisition[J]. Radiology, 2014, 271(2): 426-434. DOI: 10.1148/radiol.13131988.
|
[10] |
van KESSEL CS, VELDHUIS WB, van den BOSCH MA, et al. MR liver imaging with Gd-EOB-DTPA: A delay time of 10 minutes is sufficient for lesion characterisation[J]. Eur Radiol, 2012, 22(10): 2153-2160. DOI: 10.1007/s00330-012-2486-2.
|
[11] |
ESTERSON YB, FLUSBERG M, OH S, et al. Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: Associated clinical and imaging factors[J]. Clin Radiol, 2015, 70(7): 723-729. DOI: 10.1016/j.crad.2015.03.005.
|
[12] |
BASHIR MR, MERKLE EM. Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging[J]. Eur Radiol, 2011, 21(2): 291-294. DOI: 10.1007/s00330-010-1917-1.
|
[13] |
YANG ZH, FENG F, WANG XY. A guide to technique of magnetic resonance imaging[M]. Beijing: People's Military Medical Press, 2007: 185-212.
杨正汉, 冯逢, 王霄英. 磁共振成像技术指南[M]. 北京: 人民军医出版社, 2007: 185-212.
|
[14] |
SATO T, KONDO F, EBARA M, et al. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study[J]. Hepatol Int, 2015, 9(2): 330-336. DOI: 10.1007/s12072-015-9620-6.
|
[15] |
NIU ZS, NIU XJ, WANG WH, et al. Latest developments in precancerous lesions of hepatocellular carcinoma[J]. World J Gastroenterol, 2016, 22(12): 3305-3314. DOI: 10.3748/wjg.v22.i12.3305.
|
[16] |
European Association for the study of the liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2012, 56(4): 908-943. DOI: 10.1016/j.jhep.2011.12.001.
|
[17] |
TERRAULT NA, LOK A, MCMAHON BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67(4): 1560-1599. DOI: 10.1002/hep.29800.
|
[18] |
OMATA M, CHENG AL, KOKUDO N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: A 2017 update[J]. Hepatol Int, 2017, 11(4): 317-370. DOI: 10.1007/s12072-017-9799-9.
|
[19] |
KIM BR, LEE JM, LEE DH, et al. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma[J]. Radiology, 2017, 285(1): 134-146. DOI: 10.1148/radiol.2017162080.
|
[20] |
SANO K, ICHIKAWA T, MOTOSUGI U, et al. Imaging study of early hepatocellular carcinoma: Usefulness of gadoxetic acid-enhanced MR imaging[J]. Radiology, 2011, 261(3): 834-844. DOI: 10.1148/radiol.11101840.
|